Kevin Moran; Chief Financial Officer, Senior Vice President, Treasurer; Vanda Pharmaceuticals Inc Mihael Polymeropoulos; Chairman of the Board, President, Chief Executive Officer; Vanda ...

WASHINGTON, May 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New Drug ...

Good afternoon, and welcome to the Quarter One 2025 Vanda Pharmaceuticals Incorporated Earnings Conference Call. I am Franz, and I will be the operator assisting you today. All lines have been ...

Vanda Pharmaceuticals reported its financial results for Q1 2025, revealing a revenue of $50 million, which fell short of the $61.02 million forecast. The company also reported a net loss of $29.5 ...

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the rejection of the biotech's stomach disorder drug last year. The FDA has ...

Vanda Pharma VNDA is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

CEO Mihael Polymeropoulos highlighted Vanda’s entry into a new growth phase, driven by multiple commercialized products and an expanding pipeline. Fanapt prescriptions reached multi-year highs ...

After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda Pharmaceuticals is pursuing a new route to establish the drug in the space.

Vanda Pharmaceuticals Inc. (Vanda) announced that the US Food and Drug Administration (FDA) informed Vanda that the New Drug Application (NDA) for Bysanti (milsaperidone) has been filed, and that at ...

WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the ...

ARLINGTON, Va. – The Washington Capitals announced additional initiatives for the ALL CAPS 2025 Playoffs, presented by Vanda Pharmaceuticals Inc., for the Eastern Conference Second Round of the ...